LNAI
Lunai Bioworks Inc. NASDAQ Listed Sep 30, 2025$1.42
-3.74%
vs $1.47
Mkt Cap $6.4M
52w Low $1.21
1.7% of range
52w High $13.28
50d MA $2.25
200d MA $3.65
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-0.5x
ROE
1273.6%
P/FCF
-3.1x
RSI (14)
13.50
ATR (14)
$0.26
Beta
0.49
50d MA
$2.25
200d MA
$3.65
Avg Volume
41.9K
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
2080 Century Park East · Los Angeles, CA 90067 · US
Data updated apr 25, 2026 7:28pm
· Source: financialmodelingprep.com